In prostate cancer cell lines, the combination was shown to suppress the p-Rb1-E2F1 signalling axis leading to inhibition of E2F1 gene targets such as BRCA1/2 and RAD51 among others [116]. Here, BRCA1 is linked to prostate carcinoma.